FDA Product Code GXP: Methyl Methacrylate For Cranioplasty
FDA product code GXP covers methyl methacrylate bone cement used for cranioplasty — surgical reconstruction of skull defects.
These acrylic materials are used to reconstruct cranial bone defects resulting from trauma, tumor resection, or decompressive craniectomy. The cement is molded intraoperatively or prefabricated as a custom implant to restore the contour and protection of the skull vault.
GXP devices are Class II medical devices, regulated under 21 CFR 882.5300 and reviewed by the FDA Neurology panel.
Leading manufacturers include Orthocon, Inc., Biomet, Inc. and Synthes (Usa).
FDA 510(k) Cleared Methyl Methacrylate For Cranioplasty Devices (Product Code GXP)
About Product Code GXP - Regulatory Context
510(k) Submission Activity
45 total 510(k) submissions under product code GXP since 1987, with 45 receiving FDA clearance (average review time: 153 days).
Submission volume has increased in recent years - 5 submissions in the last 24 months compared to 3 in the prior period - suggesting growing market activity in this device classification.
FDA 510(k) Review Time - GXP Product Code
FDA review times for GXP submissions have been consistent, averaging 152 days recently vs 154 days historically.
GXP devices are reviewed by the Neurology panel. Browse all Neurology devices →